Serina Therapeutics (SER) Current Leases (2019 - 2024)

Serina Therapeutics (SER) posted Current Leases of $200000.0 for Q2 2024, down 3.38% sequentially from $207000.0 in Q1 2024.

Serina Therapeutics (SER) Current Leases (2019 - 2024) Analysis & Trends

Serina Therapeutics has reported Current Leases for 4 years, with the latest figure at $200000.0 in Q2 2024.

Quarterly Current Leases changed N/A year-over-year to $200000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $200000.0 (changed N/A YoY) and the FY2023 annual result came in at $36000.0, changed N/A from the prior year.
Current Leases slipped to $200000.0 in Q2 2024 per SER's latest filing, from $207000.0 in the prior quarter.
Over five years, Current Leases peaked at $325000.0 in Q1 2020 and troughed at $36000.0 in Q4 2023.
A 3-year average of $182500.0 and a median of $203500.0 in 2024 frame the typical range for Current Leases.
The widest YoY moves for Current Leases: up 46.44% in 2020, down 73.86% in 2020.
Over 3 years, Current Leases stood at $109000.0 in 2020, then slumped by 66.97% to $36000.0 in 2023, then jumped by 455.56% to $200000.0 in 2024.
According to Business Quant data, Current Leases over the past three periods registered $200000.0, $207000.0, and $36000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	139.57 Bn	131.72 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	65.44 Bn	60.25 Bn	1.37 Bn	-
4	Moderna	60.06 Bn	54.93 Bn	52.00 Mn	-
5	BeOne Medicines	42.16 Bn	37.06 Bn	1.53 Bn	21.95 Mn
6	Alnylam Pharmaceuticals	31.89 Bn	28.58 Bn	992.69 Mn	45.93 Mn
7	BioNTech SE	28.11 Bn	9.72 Bn	668.28 Mn	-
8	Insmed	27.59 Bn	26.43 Bn	358.27 Mn	6.27 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	-
10	Serina Therapeutics	44.50 Mn	21.48 Mn	-	-

Download Data